NIH’s Comparative Effectiveness Plan Includes Some Studies Of “Cost Effectiveness”
This article was originally published in The Pink Sheet Daily
Executive Summary
NIH releases list of specific topics it would like researchers to study using its comparative effectiveness research funding.
You may also be interested in...
AHRQ To Put More Than Half Of Stimulus CER Funding To Evidence Generation
The Agency for Healthcare Research and Quality is planning to spend $173 million, of the $300 million allocated to it for comparative effectiveness research by the American Recovery and Reinvestment Act, on evidence generation
AHRQ To Put More Than Half Of Stimulus CER Funding To Evidence Generation
The Agency for Healthcare Research and Quality is planning to spend $173 million, of the $300 million allocated to it for comparative effectiveness research by the American Recovery and Reinvestment Act, on evidence generation
NICE Lessons On What To Expect from U.S. Comparative Effectiveness
Costs appear to be an almost inevitable part of the expanded federal comparativeness research program, and the UK's 10-year old cost-effectiveness watchdog, the National Institute of Clinical Excellence, offers strategic clues for how the U.S. biopharma industry should respond, experts from the law firm Sidley Austin law firm advise